Core needle biopsy (CNB) has become an increasingly popular ... Overall, while CNB is a valuable tool in the diagnostic workup for lymphoma, the evidence suggests that it may not always match ...

Kangkan Kalita is a reporter with The Times of India and covers issues on health, education, stories of human interest while ...

Core needle biopsy is most frequently used when breast ... The needle will be attached to a spring-loaded tool or a suction device. It will be guided into the mass with the help of an imaging ...

A range of current precision oncology clinical trials are reliant on customized, targeted NGS-panel assays in order to ...

Rad's challenges in the life sciences tools market, cautious approach, R&D spending, stake in Sartorius, and growth potential ...

In 2024, Feng received the “Mentorship Award” from ASTRO. In December, the American Society for Clinical Oncology (ASCO) ...

Via AI methodologies, trial sponsors can simulate outcomes for different clinical development pathway scenarios to evaluate ...

The global EUS needles market is projected to grow from USD 180.2 million in 2022 to USD 223.5 million by 2027, at a CAGR of 4.4%. Rising cases of gastrointestinal and pancreatic conditions are ...

Discover why Exact Sciences, a leading oncology diagnostics company, may see growth in the cancer diagnostics market with its ...

The new study a collaboration by researchers from OncoAssure, University College Dublin, and Lund University, Sweden illustrates how OncoAssure Prostate, when tested on prostate cancer biopsy ...

The minimally invasive approach has already been successfully tested in animals as a biopsy tool for tumours, though they can also deliver molecules, implant electrodes and collect data samples.